Common use of Jointly Owned Patents Clause in Contracts

Jointly Owned Patents. Appendix 1.44 Licensed Product including Human Genome Target(s), Genome Editing Protein Target(s) and Guide RNA(s) Appendix 1.44 Patents within the Licensed Technology as of the License Agreement Effective Date Appendix 9.2 Exceptions to Acuitas’ Representations and Warranties in Section 9.2 Non-Exclusive License Agreement This Non-Exclusive License Agreement (“License Agreement”), dated as of October 14, 2020 (the “License Agreement Effective Date”), is made by and between Acuitas Therapeutics, Inc., a British Columbia corporation (“Acuitas”), and Verve Therapeutics, Inc., a Delaware corporation (“Verve”). Each of Acuitas and Verve may be referred to herein as a “Party” or together as the “Parties.”